INSIGHTS ON DRUG DEVELOPMENT
-
![A Pharmaceutical Perspective]( "A Pharmaceutical Perspective On Generating And Utilizing Multiomic Data")
A Pharmaceutical Perspective On Generating And Utilizing Multiomic DataRatnakar Potla of Genentech explains how Organ-Chips enable scientists to obtain a wider variety of multiomics data to better understand biological processes.
-
![GettyImages-1087219020 Scientists wearing protective coveralls working in manufacturing laboratory]( "Solid-State Characterization Of A Small Molecule API")
Solid-State Characterization Of A Small Molecule APIEnsuring the consistency and purity of the API is paramount when developing a new drug. Learn about the importance of CRO partnerships when facing tight deadlines and complex scientific hurdles.
-
![GettyImages-1087219020 Scientists wearing protective coveralls working in manufacturing laboratory]( "Pharmaceutical Solid-State Studies")
Pharmaceutical Solid-State StudiesSolid-state characterization meticulously analyzes the physical properties of a drug in its solid form. Understand how this analysis is integrated throughout the drug development lifecycle.
-
![GettyImages-488719432-bilayer-tablet-OSD-oral-solid]( "Customized Release Through Dispersed Dosage Formats")
Customized Release Through Dispersed Dosage FormatsTypically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Formulation Development Of Enterically Protected Spray Dried Dispersions11/17/2025
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
-
Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight7/23/2024
By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.
-
Accelerating mRNA Therapy Production With Digital Innovation10/21/2025
Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.
DRUG DEVELOPMENT SOLUTIONS
-
![Avanti® JXN-30 Series]( "Avanti® JXN-30 Series: High-Speed Centrifuge")
Overcome shared lab challenges with the Avanti JXN-30 high-speed centrifuge
- 4.0 L Max Capacity
- 30,000 RPM
- 110,510 x g
-
![leica-microsystems-dm-2000-hero]( "Ergonomic System Microscopes")
Leica DM2000
With their sophisticated modular design and high-performance fluorescence, the Leica DM2000 microscopes are ideal for complex tasks in pathology, cytology, and many other applications. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
![Natoli Tablet Presses- Feature]( "Pharmaceutical Tablet Presses")
Natoli’s line of affordable tablet presses is designed, engineered, and manufactured in the U.S.A. and built on our decades of experience in the tableting industry. We know our customers want presses that efficiently meet their R&D and/or production needs.
With Natoli you have a choice in your tablet press: R&D or production, single-station or rotary, fully automated or manual. Whatever your need, Natoli’s best-in-class tablet presses can help you optimize tablet quality while saving time and reducing costs.
-
![RS-DSC]( "Microcalorimetry: RS-DSC, DSC & ITC")
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.
-
![iStock-1210343139-journey-computer-data-development]( "Where Expertise Meets Simplicity: BD PartnerPath™ Program")
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
